2-chloro-n(6)cyclopentyladenosine has been researched along with imatinib in 1 studies
Studies (2-chloro-n(6)cyclopentyladenosine) | Trials (2-chloro-n(6)cyclopentyladenosine) | Recent Studies (post-2010) (2-chloro-n(6)cyclopentyladenosine) | Studies (imatinib) | Trials (imatinib) | Recent Studies (post-2010) (imatinib) |
---|---|---|---|---|---|
252 | 0 | 43 | 236 | 0 | 157 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beck, S; Benzie, AL; Muellers, SN; Parkin, DW; Stockman, BJ | 1 |
1 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and imatinib
Article | Year |
---|---|
Adenosine/guanosine preferring nucleoside ribohydrolase is a distinct, druggable antitrichomonal target.
Topics: Adenosine; Antitrichomonal Agents; Flavonoids; High-Throughput Screening Assays; N-Glycosyl Hydrolases; Quercetin; Small Molecule Libraries; Stereoisomerism; Trichomonas vaginalis | 2015 |